已收盤 05-15 16:00:00 美东时间
+3.680
+1.06%
今日重点评级关注:HC Wainwright & Co.:维持Autolus Therapeutics"买入"评级,目标价从9美元升至10美元;Maxim Group:维持Rezolute"买入"评级,目标价从4美元升至10美元
05-15 10:49
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Citigroup analyst Matthew Heimermann maintains Everest Group (NYSE:EG) with a Neutral and raises the price target from $342 to $395.
05-13 02:49
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
UBS analyst Brian Meredith maintains Everest Group (NYSE:EG) with a Neutral and raises the price target from $370 to $374.
05-05 04:28
华盛资讯4月30日讯,Everest Group, Ltd.公布2026财年Q1业绩,公司Q1营收36.02亿美元,同比下降18.0%,归母净利润6.53亿美元,同比增长211.0%。
04-30 06:22
Everest Group (NYSE:EG) reported quarterly earnings of $16.08 per share which beat the analyst consensus estimate of $14.05 by 14.45 percent. This is a 149.3 percent increase over earnings of $6.45 per share from the
04-30 04:25
Companies Reporting Before The Bell • Extreme Networks (NASDAQ:EXTR) is likely ...
04-29 19:11